Literature DB >> 22342633

Clinical review of genetic epileptic encephalopathies.

Grace J Noh1, Y Jane Tavyev Asher, John M Graham.   

Abstract

Seizures are a frequently encountered finding in patients seen for clinical genetics evaluations. The differential diagnosis for the cause of seizures is quite diverse and complex, and more than half of all epilepsies have been attributed to a genetic cause. Given the complexity of such evaluations, we highlight the more common causes of genetic epileptic encephalopathies and emphasize the usefulness of recent technological advances. The purpose of this review is to serve as a practical guide for clinical geneticists in the evaluation and counseling of patients with genetic epileptic encephalopathies. Common syndromes will be discussed, in addition to specific seizure phenotypes, many of which are refractory to anti-epileptic agents. Divided by etiology, we overview the more common causes of infantile epileptic encephalopathies, channelopathies, syndromic, metabolic, and chromosomal entities. For each condition, we will outline the diagnostic evaluation and discuss effective treatment strategies that should be considered.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342633      PMCID: PMC3590070          DOI: 10.1016/j.ejmg.2011.12.010

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  191 in total

1.  Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities.

Authors:  C A Moore; H V Toriello; D N Abuelo; M J Bull; C J Curry; B D Hall; J V Higgins; C A Stevens; S Twersky; R Weksberg; W B Dobyns
Journal:  Am J Med Genet       Date:  1997-05-02

2.  The inv dup(15) syndrome: a clinically recognizable syndrome with altered behavior, mental retardation, and epilepsy.

Authors:  A Battaglia; F Gurrieri; E Bertini; A Bellacosa; M G Pomponi; M Paravatou-Petsotas; S Mazza; G Neri
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

3.  Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion.

Authors:  N E Bass; E Wyllie; B Cohen; S A Joseph
Journal:  J Child Neurol       Date:  1996-09       Impact factor: 1.987

Review 4.  Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome.

Authors:  Y Inoue; T Fujiwara; K Matsuda; H Kubota; M Tanaka; K Yagi; K Yamamori; Y Takahashi
Journal:  Brain       Date:  1997-06       Impact factor: 13.501

Review 5.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  D-2-hydroxyglutaric aciduria in a newborn with neurological abnormalities: a new neurometabolic disorder?

Authors:  K M Gibson; W Craigen; G E Herman; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome.

Authors:  J Clayton-Smith; B Kerr; H Brunner; L Tranebjaerg; A Magee; R C Hennekam; R F Mueller; L Brueton; M Super; J Steen-Johnsen; D Donnai
Journal:  Clin Dysmorphol       Date:  1997-10       Impact factor: 0.816

8.  Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex.

Authors:  M Goodman; S H Lamm; A Engel; C W Shepherd; O W Houser; M R Gomez
Journal:  J Child Neurol       Date:  1997-02       Impact factor: 1.987

9.  Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.

Authors:  J Aicardi; J P Mumford; C Dumas; S Wood
Journal:  Epilepsia       Date:  1996-07       Impact factor: 5.864

10.  D-2-hydroxyglutaric aciduria.

Authors:  W L Nyhan; G D Shelton; C Jakobs; B Holmes; C Bowe; C J Curry; C Vance; M Duran; L Sweetman
Journal:  J Child Neurol       Date:  1995-03       Impact factor: 1.987

View more
  6 in total

1.  Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum.

Authors:  Lina Basel-Vanagaite; Tova Hershkovitz; Eli Heyman; Miquel Raspall-Chaure; Naseebullah Kakar; Pola Smirin-Yosef; Marta Vila-Pueyo; Liora Kornreich; Holger Thiele; Harald Bode; Irina Lagovsky; Dvir Dahary; Ami Haviv; Monika Weisz Hubshman; Metsada Pasmanik-Chor; Peter Nürnberg; Doron Gothelf; Christian Kubisch; Mordechai Shohat; Alfons Macaya; Guntram Borck
Journal:  Am J Hum Genet       Date:  2013-08-08       Impact factor: 11.025

Review 2.  Epileptic Encephalopathy in Childhood: A Stepwise Approach for Identification of Underlying Genetic Causes.

Authors:  Jaina Patel; Saadet Mercimek-Mahmutoglu
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

3.  Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.

Authors:  Hongjie Yuan; Kasper B Hansen; Jing Zhang; Tyler Mark Pierson; Thomas C Markello; Karin V Fuentes Fajardo; Conisha M Holloman; Gretchen Golas; David R Adams; Cornelius F Boerkoel; William A Gahl; Stephen F Traynelis
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

4.  Proteomic change by Korean Red Ginseng in the substantia nigra of a Parkinson's disease mouse model.

Authors:  Dongsoo Kim; Sunoh Kwon; Hyongjun Jeon; Sun Ryu; Ki-Tae Ha; Seungtae Kim
Journal:  J Ginseng Res       Date:  2017-04-28       Impact factor: 6.060

5.  Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy.

Authors:  Betsy E P Ostrander; Russell J Butterfield; Brent S Pedersen; Andrew J Farrell; Ryan M Layer; Alistair Ward; Chase Miller; Tonya DiSera; Francis M Filloux; Meghan S Candee; Tara Newcomb; Joshua L Bonkowsky; Gabor T Marth; Aaron R Quinlan
Journal:  NPJ Genom Med       Date:  2018-08-13       Impact factor: 8.617

Review 6.  Liquid biopsies in epilepsy: biomarkers for etiology, diagnosis, prognosis, and therapeutics.

Authors:  Jordan H Whitlock; Tabea M Soelter; Avery S Williams; Andrew A Hardigan; Brittany N Lasseigne
Journal:  Hum Cell       Date:  2021-10-25       Impact factor: 4.174

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.